Go Ad Free

This month Ottawa tabled a stack of Order Paper Questions on COVID vaccines: Pfizer payments, residual DNA contamination known as Plasmidgate, approvals, VAERS death reports, and the science (or lack thereof) behind lockdowns.

As then Prime Minister Justin Trudeau sold vaccination as a civic duty and implemented sweeping vaccine mandates, families who were never given proper informed consent recently brought their injuries to Ottawa.

“It really affects the whole family when one person’s injured,” said Carrie Sakamoto, a severely vaccine injured Canadian. She told me at the Allison Inquiry at the beginning of September that “it just devastates everybody.”

Veterans, former elite athletes and parents of children who died testified, and Health Canada stayed silent throughout. Then, a week later, the Public Health Agency of Canada posted a portal update and a backlog number. There was no apology.

As OPQ responses begin rolling in, one is from the MP who spearheaded the inquiry, Dean Allison himself. He asked Health Canada what science proves SV40 promoter fragments in Pfizer’s vaccine are inactive, and when officials first noticed the 2021-22 spike in U.S. VAERS death reports.

The department responded not with a study, but the blanket reassurance that the fragment is inactive, has no functional role and sits below limits. For context: SV40 sequences are used in molecular biology to drive gene expression. They can interact with host DNA, but it all begs the question that if the material is inert and irrelevant, why is it there?

Internal Health Canada emails from July 2023 show officials still asking Pfizer for characterization details while authorizing additional boosters – shots that were still contaminated.

Pfizer had not disclosed the sequence to Health Canada, the FDA or the EMA at the time of submissions, and it was only after genomics expert Kevin McKernan and I made the finding public in April, agencies compared notes.

“At Health Canada, we do not view this as an urgent risk topic,” one email said, as fall booster campaigns loomed. If regulators had already concluded the fragment was harmless and below limit, why were they still seeking basic measurement information from Pifzer?

The same pattern appears in questions on residual DNA bound to lipid nanoparticles, the tiny fat bubbles that carry the modified RNA of the vaccine into cells.

Officials once again offered broad safety assurances while leaving levels, fragment size, batch variability and manufacturing controls unanswered. On deaths, they said vital statistics showed no increase linked to mRNA vaccines, cited VAERS when convenient, then treated the same database as a scare tactic.